These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15137622)

  • 21. Prevention of neurotoxin damage of 6-OHDA to dopaminergic nigral neuron by subthalamic nucleus lesions.
    Chen L; Liu Z; Tian Z; Wang Y; Li S
    Stereotact Funct Neurosurg; 2000; 75(2-3):66-75. PubMed ID: 11740172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pedunculopontine tegmental stimulation evokes striatal dopamine efflux by activation of acetylcholine and glutamate receptors in the midbrain and pons of the rat.
    Forster GL; Blaha CD
    Eur J Neurosci; 2003 Feb; 17(4):751-62. PubMed ID: 12603265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased behavioral response to dopaminergic stimulation of the subthalamic nucleus after nigrostriatal lesions.
    Mehta A; Thermos K; Chesselet MF
    Synapse; 2000 Sep; 37(4):298-307. PubMed ID: 10891867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Modeling Parkinson's disease and objectifying the nigro-striatum system dysfunction].
    Chekhonin VP; Baklaushev VP; Dmitrieva TB
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(1):59-68. PubMed ID: 14870697
    [No Abstract]   [Full Text] [Related]  

  • 25. Deep brain stimulation of subthalamic neurons increases striatal dopamine metabolism and induces contralateral circling in freely moving 6-hydroxydopamine-lesioned rats.
    Meissner W; Harnack D; Paul G; Reum T; Sohr R; Morgenstern R; Kupsch A
    Neurosci Lett; 2002 Aug; 328(2):105-8. PubMed ID: 12133566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physiologic study of the subthalamic volume.
    Zincone A; Landi A; Piolti R; Appollonio I; Mariani CB; Pezzoli G; Gaini SM; Frattola L
    Neurol Sci; 2001 Feb; 22(1):111-2. PubMed ID: 11487185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The network of causal interactions for beta oscillations in the pedunculopontine nucleus, primary motor cortex, and subthalamic nucleus of walking parkinsonian rats.
    Li M; Zhou M; Wen P; Wang Q; Yang Y; Xiao H; Xie Z; Li X; Wang N; Wang J; Luo F; Chang J; Zhang W
    Exp Neurol; 2016 Aug; 282():27-36. PubMed ID: 27163550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting the pedunculopontine nucleus in Parkinson's disease: Time to go back to the drawing board.
    Albin RL; Surmeier DJ; Tubert C; Sarter M; Müller MLTM; Bohnen NI; Dauer WT
    Mov Disord; 2018 Dec; 33(12):1871-1875. PubMed ID: 30398673
    [No Abstract]   [Full Text] [Related]  

  • 29. The role of the pedunculopontine tegmental nucleus in experimental parkinsonism in primates.
    Matsumura M; Kojima J
    Stereotact Funct Neurosurg; 2001; 77(1-4):108-15. PubMed ID: 12378066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurophysiological modulation of the subthalamic nucleus by pallidal stimulation in Parkinson's disease.
    Sterio D; Rezai A; Mogilner A; Zonenshayn M; Gracies JM; Kathirithamby K; Berić A
    J Neurol Neurosurg Psychiatry; 2002 Mar; 72(3):325-8. PubMed ID: 11861688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Substantia nigra pars reticulata units in 6-hydroxydopamine-lesioned rats: responses to striatal D2 dopamine receptor stimulation and subthalamic lesions.
    Tseng KY; Riquelme LA; Belforte JE; Pazo JH; Murer MG
    Eur J Neurosci; 2000 Jan; 12(1):247-56. PubMed ID: 10651879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of subthalamic nucleus or entopeduncular nucleus lesion on levodopa-induced neurochemical changes within the basal ganglia and on levodopa-induced motor alterations in 6-hydroxydopamine-lesioned rats.
    Périer C; Marin C; Jimenez A; Bonastre M; Tolosa E; Hirsch EC
    J Neurochem; 2003 Sep; 86(6):1328-37. PubMed ID: 12950442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lesion of the pedunculopontine nucleus reverses hyperactivity of the subthalamic nucleus and substantia nigra pars reticulata in a 6-hydroxydopamine rat model.
    Breit S; Lessmann L; Unterbrink D; Popa RC; Gasser T; Schulz JB
    Eur J Neurosci; 2006 Oct; 24(8):2275-82. PubMed ID: 17042796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CGP 56999A, a GABA(B) receptor antagonist, enhances expression of brain-derived neurotrophic factor and attenuates dopamine depletion in the rat corpus striatum following a 6-hydroxydopamine lesion of the nigrostriatal pathway.
    Enna SJ; Reisman SA; Stanford JA
    Neurosci Lett; 2006 Oct; 406(1-2):102-6. PubMed ID: 16890350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The stepping test and its learning process in different degrees of unilateral striatal lesions by 6-hydroxydopamine in rats.
    Fang X; Sugiyama K; Akamine S; Namba H
    Neurosci Res; 2006 Aug; 55(4):403-9. PubMed ID: 16730826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased responsivity of glutamate release from the substantia nigra pars reticulata to striatal NMDA receptor blockade in a model of Parkinson's disease. A dual probe microdialysis study in hemiparkinsonian rats.
    Marti M; Sbrenna S; Fuxe K; Bianchi C; Beani L; Morari M
    Eur J Neurosci; 2000 May; 12(5):1848-50. PubMed ID: 10792462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unilateral lesion of the pedunculopontine nucleus induces hyperactivity in the subthalamic nucleus and substantia nigra in the rat.
    Breit S; Lessmann L; Benazzouz A; Schulz JB
    Eur J Neurosci; 2005 Nov; 22(9):2283-94. PubMed ID: 16262666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Time-course of nigrostriatal neurodegeneration and neuroinflammation in the 6-hydroxydopamine-induced axonal and terminal lesion models of Parkinson's disease in the rat.
    Walsh S; Finn DP; Dowd E
    Neuroscience; 2011 Feb; 175():251-61. PubMed ID: 21145947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic, synaptic and behavioral impact of 5-week chronic deep brain stimulation in hemiparkinsonian rats.
    Chassain C; Melon C; Salin P; Vitale F; Couraud S; Durif F; Kerkerian-Le Goff L; Gubellini P
    J Neurochem; 2016 Mar; 136(5):1004-16. PubMed ID: 26576509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Running wheel exercise enhances recovery from nigrostriatal dopamine injury without inducing neuroprotection.
    O'Dell SJ; Gross NB; Fricks AN; Casiano BD; Nguyen TB; Marshall JF
    Neuroscience; 2007 Feb; 144(3):1141-51. PubMed ID: 17157992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.